Insider · CIK 0001886301
Harry Thomasian Jr.
cfoofficer
Files at PGEN (PRECIGEN, INC.). First filing Sep 26, 2025, latest Sep 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$40k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | PRECIGEN, INC. | $40k 11,216 shares | +2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | PGEN PRECIGEN, INC. | MOption exercise Common Stock | +10,744 | $4.72 | $51k | 268,993 | 18 d ago |
| Sep 23, 2026 | PGEN PRECIGEN, INC. | MOption exercise Common Stock | +42,918 | $2.33 | $100k | 311,911 | 18 d ago |
| Sep 23, 2026 | PGEN PRECIGEN, INC. | MOption exercise Common Stock | +2 | $0.96 | $2 | 311,913 | 18 d ago |
| Sep 23, 2026 | PGEN PRECIGEN, INC. | MOption exercise Common Stock | +1 | $1.21 | $1 | 311,914 | 18 d ago |
| Sep 23, 2026 | PGEN PRECIGEN, INC. | MOption exercise Option to Purchase Common Stock (Right to Buy)derivative | -10,744 | $0.00 | $0 | 169,256 | 18 d ago |
| Sep 23, 2026 | PGEN PRECIGEN, INC. | MOption exercise Option to Purchase Common Stock (Right to Buy)derivative | -42,918 | $0.00 | $0 | 157,082 | 18 d ago |
| Sep 23, 2026 | PGEN PRECIGEN, INC. | MOption exercise Option to Purchase Common Stock (Right to Buy)derivative | -2 | $0.00 | $0 | 46,813 | 18 d ago |
| Sep 23, 2026 | PGEN PRECIGEN, INC. | MOption exercise Option to Purchase Common Stock (Right to Buy)derivative | -1 | $0.00 | $0 | 520,999 | 18 d ago |
| Sep 25, 2025 | PGEN PRECIGEN, INC. | POpen-market purchase Common Stock | +8,284 | $3.62 | $30k | 465,694 | Sep 26, 2025 |
| Sep 26, 2025 | PGEN PRECIGEN, INC. | POpen-market purchase Common Stock | +2,932 | $3.42 | $10k | 468,626 | Sep 26, 2025 |
| Sep 12, 2025 | PGEN PRECIGEN, INC. | AGrant or award Performance Stock Unitsderivative | +125,000 | $0.00 | $0 | 125,000 | Sep 16, 2025 |
| Jun 26, 2025 | PGEN PRECIGEN, INC. | AGrant or award Restricted Stock Unitsderivative | +175,000 | $0.00 | $0 | 175,000 | Jun 27, 2025 |
| May 23, 2025 | PGEN PRECIGEN, INC. | AGrant or award Option to Purchase Common Stock (Right to Buy)derivative | +350,000 | $0.00 | $0 | 350,000 | May 27, 2025 |
| May 16, 2025 | PGEN PRECIGEN, INC. | MOption exercise Common Stock | +154,475 | - | - | 508,851 | May 16, 2025 |
| May 16, 2025 | PGEN PRECIGEN, INC. | FTax withholding Common Stock | -51,441 | $1.45 | $75k | 457,410 | May 16, 2025 |
| May 16, 2025 | PGEN PRECIGEN, INC. | MOption exercise Restricted Stock Unitsderivative | -154,475 | $0.00 | $0 | 0 | May 16, 2025 |
| Apr 17, 2025 | PGEN PRECIGEN, INC. | AGrant or award Restricted Stock Unitsderivative | +154,475 | $0.00 | $0 | 154,475 | Apr 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.